English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduIn a step likely to advance personalised cancer treatment, scientists have for the first time shown in patients that levels of biomarkers are not enough to tell which patients are likely to respond best to immunotherapy.
Tag: Oncology
UC San Diego Sanford Stem Cell Institute Launches Stem Cells Into Space
The UC San Diego Sanford Stem Cell Institute leads its first space launch, sending stem cells into space aboard the International Space Station. The NASA-partnered study will take advantage of the microgravity environment of space to study accelerated aging in stem cells.
UC San Diego Awarded $8M to Expand Stem Cell Therapy Clinical Trials
UC San Diego Alpha Stem Cell Clinic awarded $8M to expand clinical trials of novel stem cell therapies. The CIRM award will advance partnerships between academic and industry experts in San Diego to expedite clinical trials for patients with difficult-to-treat diseases.
Study Shows Promising Safety, Patient Outcomes Data for MRI-Guided Adaptive Radiation Therapy to Treat Pancreatic Cancer
Findings from a recent prospective study show promising safety and patient outcomes data for locally advanced and borderline resectable pancreatic cancer treatment using ablative Stereotactic MRI-Guided On-table Adaptive Radiation Therapy, also known as SMART.
AI and Cancer: Study Highlights Automated System to Calculate Metabolic Tumor Volume
AI-based approach could make it easier to incorporate metabolic tumor volume into clinical trials and possibly patient care
New Study Shows Cancer Mortality Higher Among American Indian and Alaska Native Individuals; Colorectal Cancer Rapidly Increasing Before Age 50
New findings by researchers at the American Cancer Society show overall cancer mortality among American Indian and Alaska Native individuals is 18% higher than among White individuals despite similar cancer incidence. This disparity is driven by common cancers that are receptive to early detection.
In His Blood
A former fellow at the UNM Comprehensive Cancer Center, Dr. Shashank Cingam comes back to New Mexico to Treat blood cancers.
The Role of H. pylori in Gastric Cancer
Helicobacter pylori (H. pylori) infection is a major cause of gastric cancer, and researchers at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have several projects underway to better understand the association and develop much-needed prevention and treatment.
New Study Shows Recently Diagnosed Adult Cancer Survivors at Higher Risk for Bone Fractures
Adult cancer survivors, particularly those diagnosed within five years and/or have a history of chemotherapy, have an increased risk for bone fractures, specifically pelvic and vertebral fractures, compared to older adults without cancer, according to a new large study by researchers at the American Cancer Society.
New Optimism on Myelodysplastic Syndromes
Physician scientists at Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine have published a review in the Journal of the American Medical Association that clarifies current treatment approaches for myelodysplastic syndromes (MDS), which are rare and often deadly bone…
Dr. Antonio Iavarone Is Committed to Changing How We Treat Brain Tumors
Antonio Iavarone, M.D., has made a decades-long commitment to finding better treatments for glioblastoma and other aggressive brain tumors. As the new deputy director of Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine, he will have opportunities to do even more.
Oncology therapy at the end-of-life: Have we missed the mark?
In a study published today in JAMA Oncology, researchers at Yale Cancer Center in collaboration with researchers from Flatiron Health, Inc., revealed that despite recommendations, aggressive cancer care at the end-of-life persists and there has been a substantial transition from the use of chemotherapy to immunotherapy.
Mortality Disparities by Education Widened in the U.S. During COVID-19, New Study Shows
New findings by the American Cancer Society showed disparities in mortality rates by educational attainment as a measure of socio-economic status considerably increased in 2020 compared to prior years.
Three of the world’s top research institutions join forces to drive progress against pediatric cancer
Large-scale collaboration will leverage each institution’s expertise and infrastructure to advance understanding of the biological basis of pediatric cancers, identify new vulnerabilities of these diseases and accelerate cures globally.
Ochsner Health pulmonologist available to discuss lung screening for Healthy Lung Month
All organs are vital to sustaining life, and all require oxygen to properly function. This is what makes our lungs important and why maintaining healthy lungs is critical. Sometimes that’s as easy as not smoking, avoiding pollutants, and exercising. Other…
More than 16,000 Cancer Deaths Due to Complications from COVID-19 in 2020 in U.S., New Study Says
From March through December 2020, more than 16,000 cancer deaths were due to complications of COVID-19 in the United States, according to a new study led by researchers at the American Cancer Society.
Breast Cancer Expert: “Awareness and Early Detection Save Lives”
One in eight women will be diagnosed with breast cancer in her lifetime. For those with BRCA1 and BRCA2 gene mutations, the chances are even higher. The National Breast Cancer Foundation estimates that 55 to 65% of women with the BRCA1 mutation, and 45%…
Global Experts Introduce Strategic Action Plan to Accelerate Patient Access to Next-Generation DNA Sequencing in Oncology
Value & Outcomes Spotlight, the health economics and outcomes research (HEOR) news magazine of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a supplement, “A Plan of Action: Accelerating Patient Access to Next-Generation Sequencing in Oncology.”
St. Jude Comprehensive Cancer Center receives Merit Extension Award from NCI
The St. Jude Comprehensive Cancer Center award extends its current $35 million, five-year Cancer Center Support Grant (CCSG) for an additional two years.
New Study Shows Sugar-Sweetened Drinks Increase Risk of Cancer Mortality
In a large study led by researchers at the American Cancer Society, men and women who drank two or more servings of sugar-sweetened beverages (SSB) per day, compared to people who never drank, had a five percent increased risk of death from an obesity-related cancer, including gastrointestinal, postmenopausal breast, endometrial and kidney cancer.
New Study Shows Patients Paying More Out-of-Pocket Costs for Cancer Care
A new, large study led by researchers at the American Cancer Society and The University of Texas MD Anderson Cancer Center shows rising costs of cancer treatments led to increases in total costs of care, and when compounded with greater cost sharing, increased out-of-pocket costs for privately insured, patients under 65 years old.
Advancing Precision Oncology, Ochsner Health First to Fully Integrate with Tempus and Epic’s Genomics Module
Ochsner Health, through its Precision Medicine Program, is the first in the nation to incorporate Epic’s Orders and Results Anywhere integration with its Genomics module.
Immunotherapy Covered in Special Edition of Current Clinical Pathology
In the latest Current Clinical Pathology publication on Immunotherapy, Sbarro Health Research Organization (SHRO) President, Antonio Giordano, M.D., Ph.D., co-edits the volume, focused on cardiovascular toxicities.
Traditional Chinese medicine reduces side effect of cancer treatment
For tens of thousands of Australians who receive radiotherapy as part of their cancer treatment, mucositis is a serious side effect that may cause inflammation, ulcers, diarrhoea, nausea and vomiting, abdominal pain and bloating. Currently there is no effective treatment for mucositis, but researchers from the University of Adelaide have found that a type of traditional Chinese medicine reduces the severity of radiation-induced gastrointestinal mucositis (GIM) in rats.
New Study Shows Two Million Life-Years Lost and $21 Billion in Lost Earnings Annually Due to Smoking Associated Cancer Deaths
A new study led by researchers at the American Cancer Society reports nearly 123,000 cancer deaths, or close to 30 percent of all cancer deaths, were from cigarette smoking in the United States in 2019, leading to more than two million Person-Years of Lost Life (PYLL) and nearly $21 billion in annual lost earnings. These losses were disproportionately higher in states with weaker tobacco control policies in the South and Midwest. The results were published today in the International Journal of Cancer.
Study Shows Fewer People Tried to Quit Smoking During COVID-19 Pandemic
A new study led by researchers at the American Cancer Society shows serious smoking cessation activity declined among adults in the United States immediately after the onset of COVID-19 and persisted for over a year. Declines in attempts to quit smoking were largest among persons experiencing disproportionately negative outcomes during COVID-19, including Black people, people with comorbidities, middle-aged people, and lower educated people. The data was published today in the Journal of the American Medical Association (JAMA) Network Open.
Hormone Replacement Therapy Doesn’t Lead to Breast Cancer Reoccurrence
A new paper in the Journal of the National Cancer Institute, published by Oxford University Press, finds that menopausal hormone therapy for breast cancer survivors is not associated with breast cancer reoccurrence, despite worries among some researchers and physicians.
Penn Medicine Awarded $9 Million to Advance Study of Technology that Lights Up Lung Cancer Tumors
Building on Penn Medicine’s years of research and use of imaging technology that illuminates tumor tissue—helping clinicians more easily detect and remove it—the Perelman School of Medicine at the University of Pennsylvania has received a five-year, $9 million research grant from the National Cancer Institute (NCI) to push the field forward, particularly for lung cancer patients.
Study of Anti-Cancer Mitochondrial Drug Shows Additional Clinical Promise
A study of the lead agent (CPI-613) in a class of anticancer drugs undergoing Food and Drug Administration (FDA) approved clinical trials reveals that CPI-613 is effective against most carcinoma cell lines, and, used in combination, could have efficacy against reducing some tumors.
Study Shows Public Perception of E-Cigarettes vs. Cigarettes Harms Changed Sharply During EVALI Epidemic and COVID-19 Pandemic
A new study led by researchers at the American Cancer Society shows perceptions of electronic or e-cigarettes as being “more harmful” than cigarettes by adults in the United States more than doubled between 2019-2020 and perceptions of e-cigarettes as “less harmful” declined between 2018-2020.
Henry Ford Health is First in the World to Offer Latest Advancement in MR-Guided Radiation Therapy
Henry Ford Health is the first in the world to complete a full course of patient treatments using the latest advancement in magnetic resonance (MR)-guided radiation therapy, which integrates real-time magnetic resonance imaging (MRI) and linear acceleration to deliver precise and accurate radiation treatment more rapidly than ever before.
Pediatric Lymphoma Trial and Study of FLT3 Inhibitor for Leukemia Highlight Roswell Park Research at ASCO22
Researchers from Roswell Park Comprehensive Cancer Center will present the latest results of clinical trials and insights on cancer treatment and issues affecting patients with cancer, including the financial burdens induced by cancer treatment, at the annual meeting of the American Society of Clinical Oncology (ASCO), which will take place both online and in-person in Chicago, Illinois, from June 3 to 7.
CEC Oncology to Publish Four Abstracts at the 2022 ASCO Annual Meeting
CEC Oncology, the oncology arm of CE Concepts, LLC (CEC) and a subsidiary of KnowFully Learning Group, announces four abstracts accepted for publication in the Professional Development and Education Advances track of the 2022 ASCO Annual Meeting (https://conferences.asco.org/am/attend #ASCO22).
Rutgers Cancer Institute of New Jersey RWJBarnabas Health Facilities Receive First Regional Accreditation by American College of Radiology
Rutgers Cancer Institute of New Jersey Department of Radiation Oncology at Robert Wood Johnson University Hospital New Brunswick, Somerset and Hamilton, all RWJBarnabas Health facilities, received their first regional accreditation by the American College of Radiology (ACR).
Meta-Analysis Shows Targeted Radiation Therapy May Be as Effective as Standard Care for Small Cell Lung Cancer Patients with Brain Metastases
A study published in The Lancet Oncology suggests that a targeted radiation therapy is equitable to the current standard of care for patients whose lung cancer has metastasized to the brain.
New Study Finds Medicaid Expansion Increases Survival in Newly Diagnosed Cancer Patients
A new large study led by researchers at the American Cancer Society (ACS) shows Medicaid expansion under the Affordable Care Act (ACA) was associated with an increase in two-year overall survival rates among patients newly diagnosed with cancer, especially among non-Hispanic Black people and people living in rural areas.
New Study Reports Need to Monitor Public Interest in Shopping and Sales of Popular Puff Bar E-cigarette Brand
New research led by scientists at the American Cancer Society shows the need for continued surveillance of the changes in shopping interest and sales for Puff Bar, the most preferred brand of electronic cigarettes or e-cigarettes among youth in the United States. Public interest in shopping and sales of Puff Bar skyrocketed in 2020.
New Study Shows Adolescent and Young Adult Cancer Survivors Face Increased Cancer Incidence and Mortality Risk
New findings led by researchers at the American Cancer Society (ACS) show that five-year survivors of adolescent and young adult (AYA) cancer in the United States have a higher risk of developing and nearly double the risk of dying from a new primary cancer as the general population.
Oncology specialists’ perspective on caring for patients with cancer during the early days of war in Kyiv, Ukraine
Recently, members of The Institute for Cancer Care at Mercy Medical Center oncology research team, working in conjunction with two oncologists in war-torn Ukraine, developed a report now appearing in THE LANCET/Oncology, describing the challenges faced in cancer care delivery under…
Studies Find Increase in Use of Proton Beam Therapy for Cancer Care and Increase in Racial Disparities
Two new large studies led by researchers at the American Cancer Society (ACS) show an increase in the use of proton beam therapy (PBT) for patients with cancer in the United States during the past decade.
Yale Cancer Center Study Shows Rates of PSA Testing for Prostate Cancer Increased After Revised National Guidelines
In a large study led by Yale Cancer Center, more men received a prostate-specific antigen or PSA test to detect prostate cancer following revisions to the recommendation by the U.S. Preventative Services Task Force on screening. The results also showed significant increases in PSA testing among older men, a group for whom screening is not routinely recommended.
CHOP-led Pediatric Hospital Network Receives Critical Government Support for Genetic Research of Pediatric Tumors
The Center for Data Driven Discovery at CHOP will procure molecular characterization for thousands of these brain tumor samples providing an unprecedented level of insight into devastating cancers and paving the way for future therapeutic interventions.
Yale Cancer Center Study Shows New Strategy to Fight Drug Resistance in HER2-Positive Breast and Ovarian Cancers
New findings by researchers at Yale Cancer Center demonstrate a novel strategy to treat tumor growth in breast and ovarian cancers characterized by HER2 gene amplification, an increase in the number of copies of a gene.
Multi-Algorithm Approach Helps Deliver Personalized Medicine for Cancer Patients
John F. McDonald and his research team have created a ‘multi-algorithm’ machine learning approach to boost accuracy in predicting drug responses for ovarian cancer patients.
Long-term survivors of childhood cancer may face higher suicide risk
Survivors of childhood cancer have increased risks of experiencing various challenges, such as emotional distress, impaired quality of life, and financial burdens.
Engineering CAR T Cells to Deliver Endogenous RNA Wakes Solid Tumors to Respond to Therapy
New study shows CAR T cells expressing RN7SL1 can activate the body’s natural immune cells against difficult-to-treat cancers
Two Studies Seek to Go Beyond the GIST of Intestinal Tract Cancer
UC San Diego researchers identify the mutational drivers for gastrointestinal stroma tumors in the stomach and find a potential drug to treat a subset of GIST tumors afflicting the young.
Sylvester Comprehensive Cancer Center Researchers Awarded Major Multi-Center Grant to Study Uveal Melanoma
Researchers at the Sylvester Comprehensive Cancer Center in the University of Miami Miller School of Medicine, Moffitt Cancer Center and the University of Florida Health Cancer Center received a five-year, $3.95 million NIH grant to study how uveal melanoma spreads to the liver. This work was previously supported by two Florida State Team Science Awards, which provided early-stage funding to help the team progress to the larger NIH grant.
Yale Cancer Center Perspective Highlights New Advances for NSCLC
A new publication by Yale Cancer Center highlights recent breakthrough therapies developed to treat non-small cell lung cancer (NSCLC). The goal of the study is to provide views on how basic science advances will impact clinical research areas to help influence how NSCLC will be managed over the coming decade.
Cancer treatment and research ‘brain gain’
Cancer patients will benefit from world-class research and new treatments with the appointment of three globally-lauded scientists to the University of Adelaide’s South Australian immunoGENomics Cancer Institute (SAiGENCI).